187 related articles for article (PubMed ID: 14598229)
61. Localized proton magnetic resonance spectroscopy in patients with adult adrenoleukodystrophy. Increase of choline compounds in normal appearing white matter.
Tourbah A; Stievenart JL; Iba-Zizen MT; Lubetzki C; Baumann N; Eymard B; Moser HW; Lyon-Caen O; Cabanis EA
Arch Neurol; 1997 May; 54(5):586-92. PubMed ID: 9152115
[TBL] [Abstract][Full Text] [Related]
62. X-linked adrenoleukodystrophy: clinical course and minimal incidence in South Brazil.
Jardim LB; da Silva AC; Blank D; Villanueva MM; Renck L; Costa ML; Vargas CR; Deon M; Coelho Dl; Vedolin L; de Castro CG; Gregianin L; Bonfim C; Giugliani R
Brain Dev; 2010 Mar; 32(3):180-90. PubMed ID: 19269120
[TBL] [Abstract][Full Text] [Related]
63. Neurocognitive Trajectory of Boys Who Received a Hematopoietic Stem Cell Transplant at an Early Stage of Childhood Cerebral Adrenoleukodystrophy.
Pierpont EI; Eisengart JB; Shanley R; Nascene D; Raymond GV; Shapiro EG; Ziegler RS; Orchard PJ; Miller WP
JAMA Neurol; 2017 Jun; 74(6):710-717. PubMed ID: 28418523
[TBL] [Abstract][Full Text] [Related]
64. Quantitative proton magnetic resonance spectroscopy of cerebral metabolic disturbances in patients with MELAS.
Wilichowski E; Pouwels PJ; Frahm J; Hanefeld F
Neuropediatrics; 1999 Oct; 30(5):256-63. PubMed ID: 10598837
[TBL] [Abstract][Full Text] [Related]
65. Survival and Functional Outcomes in Boys with Cerebral Adrenoleukodystrophy with and without Hematopoietic Stem Cell Transplantation.
Raymond GV; Aubourg P; Paker A; Escolar M; Fischer A; Blanche S; Baruchel A; Dalle JH; Michel G; Prasad V; Miller W; Paadre S; Balser J; Kurtzberg J; Nascene DR; Orchard PJ; Lund T
Biol Blood Marrow Transplant; 2019 Mar; 25(3):538-548. PubMed ID: 30292747
[TBL] [Abstract][Full Text] [Related]
66. MRI and proton MRSI in women heterozygous for X-linked adrenoleukodystrophy.
Fatemi A; Barker PB; Uluğ AM; Nagae-Poetscher LM; Beauchamp NJ; Moser AB; Raymond GV; Moser HW; Naidu S
Neurology; 2003 Apr; 60(8):1301-7. PubMed ID: 12707433
[TBL] [Abstract][Full Text] [Related]
67. Adrenal functions in children with adrenoleukodystrophy.
Supornsilchai V; Wacharasindhu S; Desudchit T
J Med Assoc Thai; 2002 Jun; 85 Suppl 1():S286-92. PubMed ID: 12188425
[TBL] [Abstract][Full Text] [Related]
68. [Early changes in magnetic resonance tomography in adrenoleukomyeloneuropathy].
Otto V; Reilmann L
Nervenarzt; 1994 Apr; 65(4):264-6. PubMed ID: 8015634
[TBL] [Abstract][Full Text] [Related]
69. Potential Risks to Stable Long-term Outcome of Allogeneic Hematopoietic Stem Cell Transplantation for Children With Cerebral X-linked Adrenoleukodystrophy.
Kühl JS; Kupper J; Baqué H; Ebell W; Gärtner J; Korenke C; Spors B; Steffen IG; Strauss G; Voigt S; Weschke B; Weddige A; Köhler W; Steinfeld R
JAMA Netw Open; 2018 Jul; 1(3):e180769. PubMed ID: 30646031
[TBL] [Abstract][Full Text] [Related]
70. Localised proton magnetic resonance spectroscopy in X-linked adrenoleukodystrophy.
Confort-Gouny S; Vion-Dury J; Chabrol B; Nicoli F; Cozzone PJ
Neuroradiology; 1995 Oct; 37(7):568-75. PubMed ID: 8570058
[TBL] [Abstract][Full Text] [Related]
71. Arrested cerebral adrenoleukodystrophy: a clinical and proton magnetic resonance spectroscopy study in three patients.
Korenke GC; Pouwels PJ; Frahm J; Hunneman DH; Stoeckler S; Krasemann E; Jost W; Hanefeld F
Pediatr Neurol; 1996 Sep; 15(2):103-7. PubMed ID: 8888042
[TBL] [Abstract][Full Text] [Related]
72. Long-term adaptive functioning outcomes of children with inherited metabolic and genetic diseases treated with hematopoietic stem cell transplantation in a single large pediatric center: parents' perspective.
Gassas A; Raiman J; White L; Schechter T; Clarke J; Doyle J
J Pediatr Hematol Oncol; 2011 Apr; 33(3):216-20. PubMed ID: 21336168
[TBL] [Abstract][Full Text] [Related]
73. Brain metabolic impairment in non-cerebral and cerebral forms of X-linked adrenoleukodystrophy by proton MRS: identification of metabolic patterns by discriminant analysis.
Salvan AM; Confort-Gouny S; Chabrol B; Cozzone PJ; Vion-Dury J
Magn Reson Med; 1999 Jun; 41(6):1119-26. PubMed ID: 10371443
[TBL] [Abstract][Full Text] [Related]
74. Childhood X-linked adrenoleukodystrophy: clinical-pathologic overview and MR imaging manifestations at initial evaluation and follow-up.
Kim JH; Kim HJ
Radiographics; 2005; 25(3):619-31. PubMed ID: 15888613
[TBL] [Abstract][Full Text] [Related]
75. [Endocrine disease in adrenoleukodystrophy].
Girard S; Bruckert E; Turpin G
Ann Med Interne (Paris); 2001 Feb; 152(1):15-26. PubMed ID: 11240421
[TBL] [Abstract][Full Text] [Related]
76. Proton MRS: lactate.
Cendes F
Adv Neurol; 2000; 83():247-51. PubMed ID: 10999206
[No Abstract] [Full Text] [Related]
77. Transplant outcomes in leukodystrophies.
Orchard PJ; Tolar J
Semin Hematol; 2010 Jan; 47(1):70-8. PubMed ID: 20109614
[TBL] [Abstract][Full Text] [Related]
78. Cerebral proton magnetic resonance spectroscopy in infantile Alexander disease.
Brockmann K; Dechent P; Meins M; Haupt M; Sperner J; Stephani U; Frahm J; Hanefeld F
J Neurol; 2003 Mar; 250(3):300-6. PubMed ID: 12638020
[TBL] [Abstract][Full Text] [Related]
79. Proton NMR spectroscopy of cerebral metabolic alterations in infantile peroxisomal disorders.
Bruhn H; Kruse B; Korenke GC; Hanefeld F; Hänicke W; Merboldt KD; Frahm J
J Comput Assist Tomogr; 1992; 16(3):335-44. PubMed ID: 1592912
[TBL] [Abstract][Full Text] [Related]
80. Childhood Cerebral Adrenoleukodystrophy: MR Perfusion Measurements and Their Use in Predicting Clinical Outcome after Hematopoietic Stem Cell Transplantation.
McKinney AM; Benson JC; Nascene DR; Eisengart J; Salmela MB; Loes DJ; Zhang L; Patel K; Raymond GV; Miller WP
AJNR Am J Neuroradiol; 2016 Sep; 37(9):1713-20. PubMed ID: 27079370
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
